Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Asset Utilization Ratio: 2013-2025

Historic Asset Utilization Ratio for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to 0.43.

  • CorMedix's Asset Utilization Ratio rose 152.91% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 152.91%. This contributed to the annual value of 0.00 for FY2022, which is 69.07% down from last year.
  • CorMedix's Asset Utilization Ratio amounted to 0.43 in Q3 2025, which was down 29.30% from 0.60 recorded in Q2 2025.
  • CorMedix's 5-year Asset Utilization Ratio high stood at 0.61 for Q1 2025, and its period low was -0.00 during Q2 2024.
  • Its 3-year average for Asset Utilization Ratio is 0.22, with a median of 0.08 in 2023.
  • Data for CorMedix's Asset Utilization Ratio shows a peak YoY increase of 638,871.92% (in 2024) and a maximum YoY decrease of 249.31% (in 2024) over the last 5 years.
  • Over the past 5 years, CorMedix's Asset Utilization Ratio (Quarterly) stood at 0.00 in 2021, then crashed by 60.16% to 0.00 in 2022, then slumped by 98.14% to 0.00 in 2023, then surged by 638,871.92% to 0.43 in 2024, then surged by 152.91% to 0.43 in 2025.
  • Its Asset Utilization Ratio was 0.43 in Q3 2025, compared to 0.60 in Q2 2025 and 0.61 in Q1 2025.